stockrow
Saturday 7 November 2026
Export DMRA’s income statement to Excel — free account
Galecto, Inc.
DMRA Healthcare Biotechnology
- EPS
- +78.1%
- Free cash flow
- −877.5%
Quarter to September 2026, against a year earlier
23.67
1.81
+8.28%
Follow DMRA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
14.80 | 19.73 | 22.48 | 12.98 |
+8 more quarters Free account |
Net Debt/EBITDA |
14.23 | 15.45 | 17.30 | 1.28 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.70 | 0.70 | 0.97 | 0.15 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.28) | (0.36) | (0.60) | 0.42 | |
Cash per Share |
8.55 | 8.84 | 15.54 | 189.01 | |
Shareholders Equity per Share |
8.02 | 8.44 | 14.92 | 176.36 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.02 | 8.44 | 14.92 | 176.36 | |
Free Cash Flow |
(17.23) | (21.87) | (20.60) | 0.57 | |
Working Capital |
495.43 | 516.04 | 511.60 | 240.36 | |
Net Current Asset Value |
494.45 | 516.01 | 511.57 | 240.28 | |
| Other line items | |||||
Quick Ratio |
14.72 | 19.62 | 22.38 | 12.84 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.28) | (0.36) | (0.60) | 0.42 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
5.78 | 4.95 | 6.59 | 9.02 | |
Average Assets |
271.68 | 278.66 | 275.40 | 138.83 | |
Average Common Equity |
186.22 | 197.84 | 195.75 | (80.70) |
Columns are period end dates · fundamentals updated 6 Nov 2026